Flow cytometric DNA analysis of stage I endometrial carcinoma
Authors:
- Timothy O. WilsonTWTimothy O. Wilson
- Thomas A. GaffeyTGThomas A. Gaffey
- Michael M. LieberMLMichael M. Lieber
- Harry S. WieandHWHarry S. Wieand
- Karl C. PodratzKPKarl C. Podratz
- 1 September 1989
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 34 (3) , 317-322
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Peritoneal cytology in patients with endometrial carcinomaGynecologic Oncology, 1988
- Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometriumAmerican Journal of Obstetrics and Gynecology, 1988
- Prognostic factors and sites of failure in figo Stage I, Grade 3 endometrial carcinomaGynecologic Oncology, 1987
- Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometriumGynecologic Oncology, 1987
- Morphometric Analysis of Endometnal AdenocarcinomaInternational Journal of Gynecological Pathology, 1987
- Prognostic Factors in Early Carcinoma of the EndometriumAmerican Journal of Clinical Oncology, 1987
- Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Adenocarcinoma corpus et colli: Analysis of diagnostic variablesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- Carcinoma of the endometrium: Stage IAmerican Journal of Obstetrics and Gynecology, 1980